[Monitor] More than 1,000 people are reportedly at risk of missing the second immunisation cycle against Hepatitis B due to stock-outs at Bupandengo Health Centre III in Nawanyago Sub-county, Kamuli District.

Related Links:

The objective of the study was to determine compliance with hepatitis-B virus (HBV) in newborns in Lima and Callao. A descriptive, cross-sectional, multicenter-design study was conducted in high level public and private hospitals. Information on vaccination corresponds to newborns during one week of 2015 and was obtained through consultations with parents and review of health service reports. The study was conducted in 12 health facilities including 935 mothers and newborns. Vaccination coverage within 24 hours of life was 85.1%, according to the parents’ report; and 88.7%, according to the health services’ report. It is c…

Conclusions: NSIs were seen in all the categories of HCWs, but the awareness regarding health hazards due to NSI was inadequate. Except Class IV workers, rest of the HCWs were overall aware regarding hepatitis B vaccination. There is a need to give emphasis as regards to awareness of PEP in case of a NSI.

Abstract
BACKGROUND: China’s immunization program is one of the oldest and largest in the world. Rates of vaccine-preventable diseases (VPD) are comparable to those in high-income countries. The program’s evolution has been characterized by ambitious target setting and innovative strategies that have not been widely described.
METHODS: We reviewed national and provincial health department archives; analyzed disease surveillance, vaccination coverage, and serosurvey data from 1950 through 2016; and, conducted in-depth interviews with senior Chinese experts involved early VPD control efforts.
RESULTS: Wide…

Source: VaccineCategory: Allergy & Immunology Authors: Tags: Vaccine Source Type: research

BACKGROUND:Globally, about 300 million people are infected with hepatitis B virus (HBV). Among the effective approaches to fight HBV infection is immunization. In 1989, an obligatory hepatitis B vaccine program was launched in Saudi Arabia.  OBJECTIVE:Assess hepatitis B surface antibody (anti-HBs) levels among the medical students before and after receiving booster doses of HBV vaccine. DESIGN: Cross-sectional. SETTING: Taibah University. SUBJECTS AND METHODS:Students born between 1993 and 1995 were recruited in this study from the Occupational Health Clinic. Students were screened for anti-HBs lev…

This Seminar describes the epidemiology of hepatitis B virus (HBV) infection, vaccination, pathophysiology, risk factors and management of chronic HBV infection, and existing controversies, concluding with a discussion of future prospects.

These recommendations say that the overall supply of hepatitis B vaccine to the UK has improved and vaccine is available for all indications. The temporary recommendations and other related documents will remain on gov.uk in case of future supply constraints as the same principles of prioritisation will apply.

Conclusion: Despite a good vaccination coverage (82.6%), a considerable proportion of vaccinated children remains unprotected from HBV infection. That emphasizes the need for further strengthening of the vaccination program through implementing the birth dose of HBV vaccine as recommended by WHO.

Abstract
The oral route is one of the most convenient routes for drug and/or vaccine delivery. Yet variable nature of gastrointestinal tract due to transient changes in pH, physiology, and flora throughout the gut together with hostile nature of peptide drugs/vaccines when given by this route results in limited success. Colon targeting is a recent area of interest for most of the research among which hard gelatin coated capsules is one such important and useful contrivance. The present study assesses the mucosal immunization with HBsAg loaded lyophilized nanoparticles delivered in the colonic region using enteric …

Source: International ImmunopharmacologyCategory: Allergy & Immunology Authors: Tags: Int Immunopharmacol Source Type: research

Abstract
Globally, over 300 million people are living with viral hepatitis with approximately 1.3 million deaths per year. In 2016, World Health Assembly adopted the Global Health Sector Strategy on viral hepatitis to eliminate hepatitis by 2030. Different World Health Organization member countries are working on hepatitis control strategies to achieve hepatitis elimination. So far, only 12 countries are on track to achieve hepatitis elimination targets. The aim of the study was to give an update about the progress and challenges to achieving hepatitis elimination by 2030. According to the latest data, 87% of infa…

CONCLUSION: Maternity care providers in our cohort had a strong understanding of the fundamentals of caring for pregnant patients with HBV. Continuing education should emphasize the safety of HBV vaccination in pregnancy, novel investigations in pregnancy, current evidence on the use of antivirals in pregnancy, and appropriate timelines for infant serological follow-up.
PMID: 30471876 [PubMed – as supplied by publisher]



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here